JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
NAMS Stock Price & Analysis - Newamsterdam Pharma Co. | Ledgeburg
NAMS - Newamsterdam Pharma Co. NV
USD | NASDAQ | Healthcare
Summary
Summary NAMS Stock
Financials
Financials NAMS Stock
Loading...
Loading...
Home
Stocks
Newamsterdam Pharma Co. NV (NAMS)
Stock Overview
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
100M
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
10M
20M
30M
Q2 FY23
Q3 FY23
Q4 FY23
Q1 FY24
Q2 FY24
Q3 FY24
Q4 FY24
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Company Profile
No description available
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Employees
N/A
Founded
N/A
Company Website
N/A
Investor Relations
N/A
CEO
N/A
Headquarters
NARRDEN, P7